As the patent protecting semaglutide—the drug that made Novo Nordisk one of Europe's most valuable companies—expires in ten countries, the pressure mounts for prices and market leaders alike. Already ...
Although the court agreed that the tech giant misappropriated some of Masimo’s information related to pulse oximetry technology, Apple is not barred from using it, says a California judge.
HSF Kramer hires patent litigator as partner in Germany ...
A new partner hire at the firm brings rare depth across both the ITC and district courts in technology and life sciences.
The pharma company has successfully enforced its patents against Ascent’s proposed mirabegron copy, shortly after inking ...
Janssen seeks injunctive relief after a forensic review uncovers mass downloads of trade secrets spanning oncology, neuroscience and immunology portfolios.
Research from the International Trademark Association finds in-house counsel taking on more strategic work while facing ...
To request a FREE 2-week trial subscription, please signup. NOTE - this can take up to 48hrs to be approved. For multi-user ...
With life sciences companies increasingly reliant on complex IP and licensing deals, the firm’s new hire is set to strengthen its technology transactions practice.
The event unpacked how technology, litigation trends, and global events are adding complexity while also offering benefits for legal teams under pressure to reduce costs. If you don't have a login or ...
A proposed judgment by the rivals would extend the period in which Mylan is barred from obtaining regulatory approval for its generic of the weight-loss injectable.
The telehealth platform’s shares jumped more than 40% after the news that it will sell Ozempic and Wegovy—and no longer faces a lawsuit from the Danish pharma giant. If you don't have a login or your ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results